Your browser doesn't support javascript.
loading
Lack of pharmacokinetic interaction between mexiletine and omeprazole.
Kusumoto, M; Ueno, K; Tanaka, K; Takeda, K; Mashimo, K; Kameda, T; Fujimura, Y; Shibakawa, M.
Affiliation
  • Kusumoto M; Department of Pharmacy, Maizuru Kyosai Hospital, Kyoto, Japan.
Ann Pharmacother ; 32(2): 182-4, 1998 Feb.
Article in En | MEDLINE | ID: mdl-9496401
ABSTRACT

OBJECTIVE:

To investigate the effect of omeprazole on the pharmacokinetics of mexiletine.

METHODS:

Nine healthy male Japanese volunteers participated in a crossover study. On day 1, the subjects received mexiletine 200 mg. On days 2-7, they received omeprazole 40 mg, and on day 8 they received mexiletine 200 mg and omeprazole 40 mg concomitantly. Serum concentrations of mexiletine were determined just before drug administration and at 1, 2, 3, 4, 6, 8, 12, and 24 hours on day 1 and day 8.

RESULTS:

No differences in mexiletine concentrations were observed between the two phases of the study. The mean AUCs after administration of mexiletine alone and in combination with omeprazole 40 mg/d were 6.26 and 6.20 ng.h/L, respectively.

CONCLUSIONS:

These findings suggest that omeprazole does not affect mexiletine metabolism.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Omeprazole / Enzyme Inhibitors / Mexiletine / Anti-Arrhythmia Agents / Anti-Ulcer Agents Type of study: Clinical_trials Limits: Humans / Male Country/Region as subject: Asia Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 1998 Document type: Article Affiliation country: Japón
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Omeprazole / Enzyme Inhibitors / Mexiletine / Anti-Arrhythmia Agents / Anti-Ulcer Agents Type of study: Clinical_trials Limits: Humans / Male Country/Region as subject: Asia Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 1998 Document type: Article Affiliation country: Japón
...